- Home
- SPE vs APLT Comparison
SPE vs APLT Comparison
Compare SPE & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPE
- APLT
- Stock Information
- Founded
- SPE 1993
- APLT 2016
- Country
- SPE United States
- APLT United States
- Employees
- SPE N/A
- APLT N/A
- Industry
- SPE Finance/Investors Services
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- SPE Finance
- APLT Health Care
- Exchange
- SPE Nasdaq
- APLT Nasdaq
- Market Cap
- SPE 158.8M
- APLT 128.0M
- IPO Year
- SPE N/A
- APLT 2019
- Fundamental
- Price
- SPE $15.07
- APLT $0.66
- Analyst Decision
- SPE
- APLT Buy
- Analyst Count
- SPE 0
- APLT 7
- Target Price
- SPE N/A
- APLT $6.10
- AVG Volume (30 Days)
- SPE 25.4K
- APLT 7.2M
- Earning Date
- SPE 01-01-0001
- APLT 03-05-2025
- Dividend Yield
- SPE 8.55%
- APLT N/A
- EPS Growth
- SPE N/A
- APLT N/A
- EPS
- SPE N/A
- APLT N/A
- Revenue
- SPE N/A
- APLT N/A
- Revenue This Year
- SPE N/A
- APLT N/A
- Revenue Next Year
- SPE N/A
- APLT $2,622.90
- P/E Ratio
- SPE N/A
- APLT N/A
- Revenue Growth
- SPE N/A
- APLT N/A
- 52 Week Low
- SPE $10.26
- APLT $0.60
- 52 Week High
- SPE $12.59
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- SPE 56.37
- APLT 20.72
- Support Level
- SPE $14.50
- APLT $0.61
- Resistance Level
- SPE $15.17
- APLT $0.74
- Average True Range (ATR)
- SPE 0.28
- APLT 0.10
- MACD
- SPE 0.04
- APLT 0.20
- Stochastic Oscillator
- SPE 86.36
- APLT 14.11
About SPE Special Opportunities Fund Inc
Special Opportunities Fund Inc is the United States based closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.